These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11803904)

  • 1. Monitoring microbicide coverage.
    Reprod Health Matters; 2001 Nov; 9(18):181. PubMed ID: 11803904
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives.
    Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB
    Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract.
    Barnhart KT; Stolpen A; Pretorius ES; Malamud D
    Hum Reprod; 2001 Jun; 16(6):1151-4. PubMed ID: 11387285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the amount of nonoxynol-9 remaining in the vagina up to 4 h after insertion of a vaginal contraceptive film (VCF) containing 70 mg nonoxynol-9.
    Mauck CK; Allen S; Baker JM; Barr SP; Abercrombie T; Archer DF
    Contraception; 1997 Aug; 56(2):103-10. PubMed ID: 9315419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on nonoxynol-9 as vaginal spermicide.
    Iyer V; Poddar SS
    Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):339-50. PubMed ID: 19117251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of vaginally administered nonoxynol-9 in premenopausal women.
    Barditch-Crovo P; Witter F; Hamzeh F; McPherson J; Stratton P; Alexander NJ; Trapnell CB
    Contraception; 1997 Apr; 55(4):261-3. PubMed ID: 9179459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Absorption of a vaginal contraceptive, nonoxynol (polyoxyethylene nonylphenyl ether) and its metabolism to nonylphenol in female rabbits].
    Minami Y; Iida K; Tajima H
    Yakugaku Zasshi; 2000 Mar; 120(3):298-303. PubMed ID: 10723272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing nonoxynol-9 permeation and bioactivity in cervical mucus.
    Owen DH; Dunmire EN; Plenys AM; Katz DF
    J Control Release; 1999 Jun; 60(1):23-34. PubMed ID: 10370168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on Nonoxynol-9. II. Intravaginal absorption, distribution, metabolism and excretion in rats and rabbits.
    Chvapil M; Eskelson CD; Stiffel V; Owen JA; Droegemueller W
    Contraception; 1980 Sep; 22(3):325-39. PubMed ID: 6254723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the spermicide, nonoxynol 9, on vaginal permeability in normal and ovariectomized rabbits.
    Acatürk F; Robinson JR
    Pharm Res; 1996 Jun; 13(6):950-1. PubMed ID: 8792438
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption from the vagina.
    Benziger DP; Edelson J
    Drug Metab Rev; 1983; 14(2):137-68. PubMed ID: 6301793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model.
    Patton DL; Kidder GG; Sweeney YC; Rabe LK; Clark AM; Hillier SL
    Sex Transm Dis; 1996; 23(6):461-4. PubMed ID: 8946629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of human sperm kinematics in cervical mucus due to nonoxynol-9.
    Dunmire EN; Katz DF
    Contraception; 1997 Apr; 55(4):209-17. PubMed ID: 9179452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Ideal' microbicide may be best form of protection.
    AIDS Alert; 1999 Feb; 14(2):suppl 3-4. PubMed ID: 11366179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques.
    Miller CJ; Alexander NJ; Sutjipto S; Joye SM; Hendrickx AG; Jennings M; Marx PA
    J Med Primatol; 1990; 19(3-4):401-9. PubMed ID: 2172544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa.
    Hoffman IF; Taha TE; Padian NS; Kelly CW; Welch JD; Martinson FE; Kumwenda NI; Rosenberg ZF; Chilongozi DA; Brown JM; Chirenje M; Richardson BA
    AIDS; 2004 Nov; 18(16):2191-5. PubMed ID: 15577653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of condoms and nonoxynol-9 against HIV infection: a response to Wittkowski and colleagues.
    Feldblum PJ; Weir SS; Cates W
    Am J Public Health; 1999 Jan; 89(1):108-10. PubMed ID: 9987480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.